Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	2^nd May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,722,150 (2.064%)		101 (0.000%)
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	287,600 (0.126%)		1,302,800 (0.569%)
Total	5,009,750 (2.190%)		1,302,901 (0.570%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

1. DEALINGS (Note 4)

a. Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Purchase	1,067	111.92
Purchase	137	111.91
Purchase	200	111.95
Purchase	2,106	111.94
Sale	114	111.76
Sale	41	111.79
Purchase	114	112.00
Purchase	1,490	111.93
Purchase	204	111.91
Purchase	92	111.95
Purchase	366	111.94
Purchase	1,363	111.76
Sale	995	111.76
Purchase	1	111.79
Purchase	1,252	111.89
Purchase	656	111.78
Purchase	96	111.86
Purchase	604	111.98
Purchase	351	111.97
Purchase	43	111.71
Purchase	997	111.82
Purchase	592	111.93
Purchase	239	111.81
Purchase	1,416	111.73
Purchase	581	111.77
Purchase	223	111.67
Purchase	405	111.69
Purchase	104	111.84
Purchase	6	111.88
Purchase	834	111.74
Purchase	127	111.72
Purchase	1,485	111.85
Purchase	4	111.83
Purchase	211	111.80
Purchase	6	111.66
Purchase	112	111.70
Purchase	192	111.64
Sale	66	111.76
Sale	35	111.77
Sale	100	111.92
Purchase	12	111.91
Sale	1,939	111.91
Purchase	119	111.95
Sale	200	111.95
Purchase	640	111.94
Sale	100	111.94
Purchase	1,462	111.76
Sale	691	111.76
Purchase	263	111.79
Sale	1,637	111.79
Sale	3,836	111.89
Purchase	69	111.78
Sale	3,656	111.78
Purchase	693	111.86
Sale	370	111.86
Purchase	100	111.98
Purchase	8,018	112.00
Sale	437	111.71
Purchase	541	111.82
Sale	548	111.82
Purchase	352	111.93
Sale	1,207	111.93
Purchase	5,202	111.81
Sale	3,309	111.81
Purchase	3,972	111.73
Sale	3,859	111.73
Purchase	200	111.68
Sale	98	111.68
Purchase	1,075	111.77
Sale	1,607	111.77
Sale	125	111.67
Purchase	600	111.69
Sale	3,260	111.69
Sale	4,767	111.90
Purchase	219	111.87
Sale	6,082	111.87
Purchase	664	111.84
Sale	5,576	111.84
Purchase	60	111.88
Sale	3	111.88
Purchase	467	111.74
Sale	3,848	111.74
Purchase	164	111.72
Sale	3,050	111.72
Purchase	152	111.85
Sale	5,496	111.83
Purchase	100	111.96
Purchase	104	111.80
Sale	500	111.80
Sale	6,555	111.75
Purchase	103	111.66
Sale	100	111.66
Purchase	393	111.70
Sale	645	111.70

b. Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Call Option	Writing	400	100.00	American	5/12/2023
Call Option	Writing	400	101.00	American	5/12/2023
Call Option	Writing	400	102.00	American	5/12/2023
Call Option	Writing	400	103.00	American	5/12/2023
Call Option	Writing	400	104.00	American	5/12/2023
Call Option	Writing	400	105.00	American	5/12/2023
Call Option	Writing	400	106.00	American	5/12/2023
Call Option	Writing	400	107.00	American	5/12/2023
Call Option	Writing	400	108.00	American	5/12/2023
Call Option	Writing	400	109.00	American	5/12/2023
Call Option	Writing	400	110.00	American	5/12/2023
Call Option	Writing	400	111.00	American	5/12/2023
Put Option	Writing	600	100.00	American	5/12/2023
Put Option	Writing	800	101.00	American	5/12/2023
Put Option	Writing	700	102.00	American	5/12/2023
Put Option	Writing	700	103.00	American	5/12/2023
Put Option	Writing	1,000	104.00	American	5/12/2023
Put Option	Writing	1,000	105.00	American	5/12/2023
Put Option	Writing	1,000	106.00	American	5/12/2023
Put Option	Writing	1,000	107.00	American	5/12/2023
Put Option	Writing	1,000	108.00	American	5/12/2023
Put Option	Writing	1,000	109.00	American	5/12/2023
Put Option	Writing	1,000	110.00	American	5/12/2023
Put Option	Writing	1,000	111.00	American	5/12/2023

ii. Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

d. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	3^rd May 2023
Contact name	Sirina Kumar
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	1,100	90.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	11,500	110.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Written	262,400	115.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	42,500	120.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	55,400	110.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	2,900	80.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	221,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	254,200	100.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	100,000	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	46,600	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	155,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	200,000	100.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	3,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	400	100.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	101.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	102.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	103.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	104.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	105.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	106.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	107.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	108.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	109.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	5/12/2023
IE00BQPVQZ61	Call Option	Written	400	111.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	600	100.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	800	101.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	700	102.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	700	103.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	104.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	105.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	106.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	107.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	108.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	109.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	110.00	American	5/12/2023
IE00BQPVQZ61	Put Option	Written	1,000	111.00	American	5/12/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1090306

Time of Receipt (offset from UTC): 20230503T145210+0100